ProCE Banner Activity

Practical Nursing Strategies to Optimize the Care of Patients With Lung Cancer Receiving Immunotherapy: Slideset Module

Slideset Download
In this CE-certified downloadable slideset with slidenotes from the live meeting series, Maura Abbott, PhD, AOCNP, CPNP, reviews key data and nursing considerations for patients with NSCLC receiving immune checkpoint inhibitors, including case-based management of immune-related adverse events.

Released: March 01, 2018

Expiration: February 28, 2019

No longer available for credit.

Share

Faculty

Maura Abbott

Maura Abbott, PhD, AOCNP, CPNP

Assistant Professor of Nursing
Oncology Program Director
Nurse Practitioner
Department of Hematology/Oncology
Columbia University Medical Center
New York, New York

Beth Eaby-Sandy

Beth Eaby-Sandy, MSN, CRNP, OCN

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AstraZeneca

Genentech TEXT Only

Target Audience

This program is intended for registered nurses and other healthcare providers who provide care for patients with non-small-cell lung cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe to patients the key principles underlying immunotherapy
  • Evaluate the clinical data to be able to discuss the efficacy and safety of current and emerging immune checkpoint inhibitors for NSCLC
  • Develop management strategies for immunotherapy-associated adverse events

Faculty Disclosure

Primary Author

Maura Abbott, PhD, AOCNP, CPNP

Assistant Professor of Nursing
Oncology Program Director
Nurse Practitioner
Department of Hematology/Oncology
Columbia University Medical Center
New York, New York

Maura Abbott, PhD, AOCNP, CPNP, has no real or apparent conflicts of interest to report.

Beth Eaby-Sandy, MSN, CRNP, OCN

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Beth Eaby-Sandy, MSN, CRNP, OCN, has disclosed that she has received consulting fees from AbbVie, Ariad and Takeda and fees for non-CME/CE services from Amgen, AstraZeneca, Helsinn, and Merck.

Staff Disclosure

Staff

Krista Marcello,

Associate Managing Editor

Krista Marcello has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

JA logo

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 01, 2018, through February 28, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in helping patients with non-small-cell lung cancer understand and maximally benefit from immunotherapy.